Investigating Toxic Overload and Depression A targeted history and laboratory assessment may help distinguish environmental exposure from elevated SAH, glutathione depletion, mitochondrial stress, gut-derived burden or impaired organ clearance
The recently published FLOW trial, which specifically targeted T2DM patients with CKD and used kidney-specific primary endpoints, has solidified the efficacy of GLP-1 RAs in slowing CKD progression [58]
While it's one of the most advanced options we offer, many clients report significant improvements in energy levels, immune function, and overall well-being that can last for weeks
Use within 4-6 weeks for best results
Bahne E, Sun EWL, Young RL et al (2018) Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes
Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology